ProCE Banner Activity

CAR T-Cells and Bispecific Antibodies in MM

Slideset Download
Download these expert-selected slides on current and investigational anti-BCMA CAR T-cell and bispecific therapies for relapsed/refractory multiple myeloma.

Released: September 22, 2022

Expiration: September 21, 2023

No longer available for credit.

Share

Faculty

Noopur Raje

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Medical Learning Institute, Inc. in partnership with Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by educational grants from

Janssen administered by Scientific Affairs

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Noopur Raje, MD

Director, Center for Multiple Myeloma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts